SG Americas Securities’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.1M Sell
882,720
-1,135,454
-56% -$35.8M 0.02% 464
2026
Q1
$56.5M Buy
2,018,174
+1,056,507
+110% +$34.6M 0.06% 257
2025
Q4
$36M Buy
961,667
+938,783
+4,102% +$30.9M 0.05% 301
2025
Q3
$631K Buy
22,884
+3,177
+16% +$109K ﹤0.01% 1915
2025
Q2
$623K Sell
19,707
-15,390
-44% -$495K ﹤0.01% 1501
2025
Q1
$1.17M Buy
35,097
+12,599
+56% +$452K ﹤0.01% 1065
2024
Q4
$774K Buy
22,498
+6,774
+43% +$233K ﹤0.01% 1007
2024
Q3
$629K Buy
15,724
+11,158
+244% +$392K ﹤0.01% 1484
2024
Q2
$138K Buy
+4,566
New +$137K ﹤0.01% 2369
2024
Q1
Sell
-8,945
Closed -$289K 3171
2023
Q4
$289K Sell
8,945
-11,408
-56% -$318K ﹤0.01% 1852
2023
Q3
$667K Buy
+20,353
New +$707K 0.01% 1551
2023
Q1
Sell
-2,675
Closed -$147K 3392
2022
Q4
$147K Buy
+2,675
New +$147K ﹤0.01% 2442
2022
Q3
Sell
-17,626
Closed -$860K 3342
2022
Q2
$860K Buy
17,626
+6,761
+62% +$304K 0.01% 1432
2022
Q1
$529K Sell
10,865
-7,166
-40% -$292K ﹤0.01% 1848
2021
Q4
$769K Buy
18,031
+9,825
+120% +$392K ﹤0.01% 1831
2021
Q3
$315K Buy
+8,206
New +$264K ﹤0.01% 2899

Other funds holding HRMY

SG Americas Securities's HRMY Position: Q2 2026 in Review

SG Americas Securities reduced its Harmony Biosciences (HRMY) stake by 56% in Q2 2026, selling an estimated $35.8M and leaving 882,720 shares worth $32.1M. The position accounts for 0.02% of the portfolio, ranked #464.

SG Americas Securities first reported a position in HRMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $56.5M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • SG Americas Securities held 882,720 shares of Harmony Biosciences worth $32.1M as of Q2 2026.
  • SG Americas Securities sold 1,135,454 Harmony Biosciences shares in Q2 2026, an estimated $35.8M.
  • Harmony Biosciences made up 0.02% of SG Americas Securities's portfolio in Q2 2026, its #464 holding.
  • SG Americas Securities first reported a position in Harmony Biosciences in Q3 2021 and has held it in 16 quarters since.
  • SG Americas Securities's Harmony Biosciences position peaked at $56.5M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.